WELCOME TO THE MANUFACTURING REPORT
Newsletter | Member Login | Signup
Home > Companies > BigRep GmbH
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
Conference
BigRep GmbH | October 25, 2019
In May 2019, leading large format 3D printer manufacturer BigRep broke new ground with the launch of the STUDIO G2. A successor to the original BigRep STUDIO system, the G2 is one of the first fully-enclosed 3D printers from the company, offering the same tried and true principles of its predecessors in a controlled environment, unlocking new material potential. Five months after the launch of the STUDIO G2, the company sold out of early adopter machines, and is now transitioning to and ramping ...
BigRep GmbH | November 11, 2019
BigRep has introduced four new certified materials for its large-format extrusion 3D printing systems at FABTECH in Chicago. The company has added PLX, PET-CF, PA6/66 and BVOH support material to its portfolio as it strives to facilitate more advanced applications of its Pro, Edge and Studio G2 systems. Derived from organic compounds, PLX is being pitched as a reliable material able to print up to 80% faster than standard PLA at a strength surpassing ABS-printed parts without modification to the...
Keppel Offshore & Marine, Lloyd's Register | January 14, 2020
Keppel Offshore & Marine has received Lloyd’s Register LR Certification to additively manufacture offshore grade steel with a 3D printing technology from Singapore Institute of Manufacturing Technology SIMTech. The certification was granted after assessing Keppel O&M’s production processes, from design to post-processing and testing. Partnering with Nanyang Technological University, Singapore NTU Singapore and SIMTech’s Agency for Science, Technology and Research A*STAR...
Outsourcing-Pharma.com | January 13, 2020
BMS and Catalent disclosed the deal for the site in June, at which time they hoped to work through the regulatory approvals and union consultations needed to close the transaction by the end of the year. One week into 2020, Bristol-Myers revealed it had closed the deal. The deal covers a 19,300-square-meter manufacturing facility in Anagni, a town in central Italy, that lists cardiovascular, neuroleptics, anticancer, metabolic and anti-inflammatory medicines among the drugs it makes and packages...
Smart Factory
Article
Industrial 4.0
Video
Manufacturing Technology
Whitepaper
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Welcome back!
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE